Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Copenhagen Other stock markets 08:29:55 17/05/2024 pm IST			5-day change	1st Jan Change
335 ^DKK	+1.21%		+4.56%	+13.18%

06/05	DEMANT : Q1 sales miss; organic growth guidance unchanged
06/05	Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024

Demant A/S Appoints Niels Wagner to the Board of Directors

March 04, 2022 at 11:21 am IST

Demant has completed the acquisition of 20% of the shares in ShengWang. As part of the investment in ShengWang, Niels Wagner, President of Demant's Hearing Care business, has joined the company's board of directors.

Latest news about Demant A/S

DEMANT : Q1 sales miss; organic growth guidance unchanged	06/05
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	06/05
Hearing Healthcare Company Demant Affirms FY24 Outlook	06/05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	06/05	CI
Denmark's Demant Finalizes Capital Reduction	08/04	MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04/04	MT
Demant Seeks Acquisitions	12/03	CI
Transcript : Demant A/S - Analyst/Investor Day	12/03
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	28/02	DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	07/02	CI
Nordic Shares Rose Tuesday; Demant Climbed Highest	06/02	DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	06/02
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	06/02
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024	06/02
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak	06/02	DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	06/02	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	06/02	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	06/02	MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions	05/02	MT
Demant A/S Provides Earnings Guidance for the Year 2024	05/02	CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024	03/01	CI
Demant to Recommence Share Buybacks	21/11	MT
Nordic Stocks Dropped Tuesday; Demant Took Biggest Hit	07/11	DJ
DEMANT : Sales broadly in-line; guidance narrowed	07/11
Transcript : Demant A/S, Q3 2023 Interim Management Statement Call, Nov 07, 2023	07/11

Chart Demant A/S

Duration

Period

More charts

Company Profile

Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

22/05/2024 - Deutsche Bank Conference

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 08:48 pm IST

More Strategies

Ratings for Demant A/S

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

335 DKK

Average target price

332.6 DKK

Spread / Average Target

-0.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
DEMANT A/S	+13.18%	1.06TCr
SONOVA HOLDING AG	+6.12%	1.91TCr
COCHLEAR LIMITED	+7.04%	1.45TCr
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-12.19%	220.15Cr
EMBLA MEDICAL HF.	+4.55%	178.53Cr
ANGELALIGN TECHNOLOGY INC.	+33.60%	165.5Cr
MODERN DENTAL GROUP LIMITED	+21.86%	64Cr
ANGEL ROBOTICS CO., LTD.	0.00%	38Cr
DELCATH SYSTEMS, INC.	+81.97%	21Cr
INTEGRUM AB	+19.61%	9.4Cr

Medical Prosthetics